Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell by Ioannis Karakasiliotis & Penelope Mavromara
OPINION
published: 18 May 2015
doi: 10.3389/fphys.2015.00154
Frontiers in Physiology | www.frontiersin.org 1 May 2015 | Volume 6 | Article 154
Edited by:
Eumorphia Remboutsika,
BSRC “Alexander Fleming”, Greece
Reviewed by:
Gianpaolo Papaccio,





This article was submitted to
Craniofacial Biology,
a section of the journal
Frontiers in Physiology
Received: 20 April 2015
Accepted: 28 April 2015
Published: 18 May 2015
Citation:
Karakasiliotis I and Mavromara P
(2015) Hepatocellular carcinoma: from




hepatocyte to liver cancer stem cell
Ioannis Karakasiliotis 1* and Penelope Mavromara 2
1Molecular Virology, Hellenic Pasteur Institute, Athens, Greece, 2Molecular Biology and Genetics, Democritus University of
Thrace, Alexandroupolis, Greece
Keywords: HBV, HCV, hepatocellular carcinoma, liver, stem cells
Self-renewal and the potential to yield various cell types are the main attributes of stem cells and
shared by the so called cancer stem cells (CSCs). CSCs consist a small portion of cells within the
tumor mass that are very often resistant to chemotherapy and radiation, while being responsible
for cancer relapse after treatment. The role of cancer stem cells has been recognized in cancers
such as leukemia and colon cancer, whereas their role in hepatocellular carcinoma (HCC) remains
to be unraveled. The vast majority of HCCs (∼80%) are related to Hepatitis virus B (HBV) and
C (HCV) persistent infection implicating parallel pathways of intrinsic cell transformation and
chronic infection-inflammation.
CSCs reside among other more differentiated cancer cells, are resistant to apoptosis and their
self-renewal is based on transcription factors similar to those of adult and embryonic stem
cells such as Oct4, Nanog and Klf-4. Although their origin and relationship with the tumor
initiating cell is still debatable it is rather established that they sustain tumor growth, produce
differentiated progenies that organize a hierarchical cell system and induce eventually tumor’s
metastatic potential. Recently, it has been suggested that persistent oncogenic viruses such as HBV
andHCV trigger the formation of CSCs that are possibly responsible for the high rates of recurrence
and mortality that characterize HCC.
Both HBV and HCV although very different in their genome organization and life cycle they
result often in persistent infection that leads eventually in 1–5% of infected individuals to HCC
through liver fibrosis and cirrhosis. HBV replicates its DNA in cell nucleus and remains episomally
in the form of minichromosome. HBV DNA fragments are often integrated in host genome. HCV
on the other hand is a positive strand RNA virus with cytoplasmic replication organized in virus
induced vesicles. HBx protein of HBV and HCV core, NS3, and NS5A proteins are modulators
of cellular pathways that lead to cell transformation. HBV and HCV chronic infection induce
accumulative liver damage followed by an increasing liver regeneration that is favored by both
viruses. Indeed, hepatic progenitor cells increase their numbers in the liver of HCV patients as the
disease advances to cirrhosis (Tsamandas et al., 2006), while liver CD133+ (a stemness surface
marker) CSCs correlated with early recurrence and poor prognosis among HBV related HCC
patients (Ma et al., 2010). During cirrhosis, HBV andHCVproteins support the survival and sustain
the growth of infected cells within a mayhem of inflammatory-mediated cell death.
Replication of HCV in Huh7.5 hepatoma cells in the form of a subgenomic replicon, which
bears only the non-structural proteins of HCVNS3-5B, showed marked induction of liver stem cell
markers such as Lgr5, cytokeratin-19 (CK-19) doublecortin and CaM kinase-like-1 (DCAMKL-
1) and CD133 in conjunction with liver progenitor cell makers such as α-fetoprotein (AFP).
Remarkably, curing the cells by using Interferon 2a reversed the phenomenon, while xenograft-
derived tumors of these cells in mice encompassed cells with liver progenitor and CSC traits (Ali
et al., 2011). Biopsies fromHCV-linked tumors supported the presence of DAMKL-1+ cells, whose
abundance increased with the disease stage (Ali et al., 2011). Concurrently, expression of HBx
protein of HBV in HepG2 hepatoma cells greatly enhanced the abundance of the pluripotency
transcription factors such as Oct-4, Nanog, and Klf-4, as well as the “stemness”-associated
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markers EpCAM and β-catenin (Arzumanyan et al., 2011).
Biopsies from HBV infected patients recapitulated the
overexpression of EpCAM, while Oct-4 and Nanog expressing
cells were detected within the tumors (Arzumanyan et al., 2011).
Recently, Nanog was shown to be induced by HCV core protein
through activation of STAT3. HCV core facilitated cell cycle
progression in a Nanog-dependent manner (Zhou et al., 2014).
Interestingly, Nanog was upregulated in the liver of NS5A
expressing mice, while the effect was maximized during alcohol
feeding in a TLR4-dependent manner (Machida et al., 2009).
The induction of stemness by HCV structural and non-
structural proteins through parallel pathways possibly
underscores its importance in virus proliferation and persistence.
Huh7.5 cells support HCV replication, in contrast to their
predecessors Huh7, to a great extent due to the constitutive
activation of sonic hedgehog pathway (Choi et al., 2011), which
is known to be critical for liver regeneration and the control of
CSC self-renewal. Although one cannot exclude the contribution
of innate immunity and mir-122 in cell permissiveness to
HCV. A more direct effect of stemness-related factors in HCV
replication was observed by siRNA knockdown of DCAMKL-1
which correlated well with the decline in HCV RNA abundance
(Ali et al., 2011).
Conditions within the microinviroment of the infected cells
could also play an important role in the programming of
liver cells toward CSCs and the divergence of the multiple
pathways induced by HCV and HBV toward epithelial to
mesenchymal transition (EMT) or stemness. Such condition,
which is often present in inflamed and malignant areas of the
liver, is hypoxia. Accumulated evidence from various cancer
types strongly support the hypothesis that hypoxia sustains
the self-renewal characteristics of a portion of cancer cells in
hypoxic niches mainly due to the upregulation of Oct4, NANOG,
SOX2, Klf4, and c-myc (Mathieu et al., 2011; Muz et al., 2014).
HBV and HCV modulate hypoxic pathways to adapt cells in
hypoxic conditions conferring EMT characteristics (Wilson et al.,
2011; Kim, 2014). Remarkably, hypoxic conditions induced HCV
replication in Huh7.5 cells which correlated with activation of
anaerobic cell energy production and cell proliferation (Vassilaki
et al., 2013). Thus, interplay between the induction of stemness
conditions through hypoxia and activation of cell energy status
by HCV and through that enhancement of HCV replication
may lead to a boost of both HCV spread and tumorigenesis in
chronically infected individuals.
A less evaluated parameter in HCV and HBV HCC are the
extrinsic signals of CSC sustainment. Cytokines such as IL-8
are secreted during HBV infection, while they fluctuate during
disease exacerbation periods (Dunn et al., 2007). HCV NS5A
could also induce IL-8 production and elevated IL-8 levels were
linked to resistance in interferon therapy (Polyak et al., 2001a,b).
IL-8 is known to sustain CSC self-renewal in cancers such as
breast and pancreatic cancer increasing invasiveness (Singh et al.,
2013; Chen et al., 2014). Tumor associated macrophages (TAMs)
are possibly part of the niche that sustains CSCs in breast
cancer and HCC (Fan et al., 2014; Lu et al., 2014). Especially
for HCC, TAMs sustain CSCs (EpCAM+ cells) through TGFb1
induction of EMT (Fan et al., 2014). HBx and HCV core are
the key proteins in the induction of TGFb1 signaling-dependent
EMT markers, while HCV core diverts TGFb1 signaling from
tumor suppression to EMT induction (Battaglia et al., 2009).
IL-6 is secreted by inflammatory and stromal cells during liver
regeneration and it is known to support the conversion of non-
CSCs to CSCs (Kim et al., 2013). In breast cancer IL-6 promoted
self-renewal and hypoxia survival through activation of Notch
pathway (Sansone et al., 2007). Both HCV and HBV induce IL-
6 production, while increased IL-6 levels are poor prognostic
marker for either treatment outcome (HCV, Guzman-Fulgencio
et al., 2012) or HCC severity (HBV, Chang et al., 2015). The link
between IL-6 and stemness was furthermore supported by the
high positive correlation between IL-6 levels and Oct4/Nanog
expression in HBV HCC patients (Chang et al., 2015). IL-6
sustainment of HCC progenitor cell phenotype seems to apply
even in chemically induced HCC as stemness-associated markers
and cell proliferation are linked to autocrine IL-6 activation (He
et al., 2013).
Thus, it is becoming increasingly supported that HBV and
HCV infection promotes EMT and stem cell-like characteristics
in the infected liver cells that enable them to adapt and proliferate
in the hypoxic inflammatory environment of the cirrhotic liver
paving the ground for the occurrence of HCC (Figure 1). These
characteristics seem to favor the presence of the virus in the
infected liver and are possibly associated with persistent viral
replication. As recurrence and mortality are still hallmarks of
HCC, it is becoming a central question to clarify the network of
the intrinsic induction of CSC phenotype through the activation
of EMT and stemness transcription factors and the extrinsic
sustainment of this phenotype by inflammatory and regenerative
signals. Identification of those characteristics that differentiate
liver CSCs from normal adult stem cells and liver progenitors
and dissection of the CSC niche microenvironment are critical
FIGURE 1 | HBV and HCV infection induce the expression of stemness
and progenitor-related cell markers derived either from intrinsic or
extrinsic signals that involve liver inflammation and regeneration.
Signals related to pluripotency often feedback favoring viral abundance.
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for the development of new therapies that target the root
of HCC and its potential to reinitiate tumor formation after
treatment.
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